| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Sewell Brandon Elliot | Interim CFO | 1390 ENCLAVE PARKWAY, HOUSTON | /s/Andrew Wurdack, Attorney-in-Fact | 13 Mar 2026 | 0002119429 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | SYY | Common Stock | 4,278 | 06 Mar 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | SYY | Stock Options (Right to buy) | 06 Mar 2026 | Common Stock | 2,492 | $76.94 | Direct | F1 | ||||||
| holding | SYY | Stock Options (Right to buy) | 06 Mar 2026 | Common Stock | 2,844 | $85.57 | Direct | F2 | ||||||
| holding | SYY | Stock Options (Right to buy) | 06 Mar 2026 | Common Stock | 2,507 | $73.53 | Direct | F3 | ||||||
| holding | SYY | Stock Options (Right to buy) | 06 Mar 2026 | Common Stock | 2,583 | $76.54 | Direct | F4 | ||||||
| holding | SYY | Stock Options (Right to buy) | 06 Mar 2026 | Common Stock | 5,086 | $80.98 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | One-third of the shares covered by the grant vest and are exercisable on 08/19/2022, 08/19/2023 and 08/19/2024, respectively. No options may be exercised prior to 08/20/2021. Options will expire on 08/18/2031. |
| F2 | One-third of the shares covered by the grant vest and are exercisable on 08/18/2023, 08/18/2024 and 08/18/2025, respectively. No options may be exercised prior to 08/18/2023. Options will expire on 08/17/2032. |
| F3 | One-third of the shares covered by the grant vest and are exercisable on 8/10/2024, 8/10/2025 and 8/10/2026, respectively. No options may be exercised prior to 8/10/2024. Options will expire on 8/9/2033. |
| F4 | One-third of the shares covered by the grant vest and are exercisable on 8/21/2025, 8/21/2026 and 8/21/2027, respectively. No options may be exercised prior to 8/21/2025. Options will expire on 8/20/2034. |
| F5 | Stock options granted on 08/21/2025 and become exercisable with respect to 33.3% of the total number of originally issued options on each of the first three anniversaries of the grant date. |